In summary, we demonstrated for the first time that engineered regulatory T cells targeting the pathogenic MHCII/insulin epitope with the insulin B:9-23 peptide trapped in a disease-related register could effectively and safely protect NOD.CD28-/- mice against T1D. Here, INS is linked to type 1 diabetes mellitus.